Clinical trials
Recruiting Phase 3 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Chengdu CoenBiotech Co., Ltd | 1 |
| Eli Lilly and Company | 1 |
| Fujian Medical University Union Hospital | 1 |
| Hamlet Pharma AB | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 19 |
| Neoplasms | 4 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Carcinoma, Transitional Cell | 3 |
| Neoplasm Metastasis | 2 |
| Urinary Bladder Diseases | 2 |
| Carcinoma | 1 |
| Carcinoma in Situ | 1 |
| Cystitis, Hemorrhagic | 1 |
| Cystitis, Interstitial | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.